Back to Search
Start Over
Brigatinib vs crizotinib in ALK TKI-naive ALK+ NSCLC: final results from ALTA-1L
- Source :
- Lung Cancer. 165:S27-S28
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Pulmonary and Respiratory Medicine
Cancer Research
Oncology
Subjects
Details
- ISSN :
- 01695002
- Volume :
- 165
- Database :
- OpenAIRE
- Journal :
- Lung Cancer
- Accession number :
- edsair.doi...........660ba3e0f86a2ca60f76bd5d6440094c
- Full Text :
- https://doi.org/10.1016/s0169-5002(22)00107-6